Product Program year 2020 Source: CMS Open Payments

Fluarix Quadrivalent

Biological Vaccines

NDC 58160-896-52

Open in the dashboard

General payments

$32,415

1,885 payments

Research payments

$0

0 payments

Through program year 2020, $32,415 in general payments and $0 in research payments were reported against Fluarix Quadrivalent (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $32,273 1,876
2019 General $142 9

Breakdown

Who paid General payments · program years 2019–2020
  1. GlaxoSmithKline, LLC. $32,415 1,885 payments
Top recipients General payments · program year 2020
  1. Inspira Medical Center Vineland Teaching hospital · NJ $523 2% · 1 payment
  2. Kin Lam Internal Medicine · New York, NY $166 <1% · 7 payments
  3. Bulent Atac Internal Medicine · Bronx, NY $154 <1% · 6 payments
  4. Donald Wallerson Cardiovascular Disease · Woodside, NY $150 <1% · 6 payments
  5. Amy Lichtenfeld New York, NY $147 <1% · 8 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Pediatrics $10,069 33% · 417 practitioners
  2. Family Medicine $8,186 27% · 377 practitioners
  3. Internal Medicine $7,159 23% · 318 practitioners
  4. Adolescent Medicine Pediatrics $929 3% · 35 practitioners
  5. General Practice $794 3% · 36 practitioners

The top 5 of 54 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. New York $8,195 25% · 238 recipients
  2. Texas $4,598 14% · 207 recipients
  3. Tennessee $3,920 12% · 147 recipients
  4. California $3,030 9% · 133 recipients
  5. New Jersey $1,608 5% · 53 recipients

The top 5 of 44 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,885 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record